Jasper Therapeutics, Inc. SEC filings JSPR
Jasper Therapeutics, Inc. has 483 filings in SEC EDGAR's recent list, going back to Sep 13, 2019. Its latest annual report, Form ARS, was filed on Jun 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 19, 2026 | Nov 13, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| DEF 14A | Proxy statement | Sep 4, 2026 | Sep 30, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 24, 2026 | Aug 24, 2026 |
| DEFA14A | Additional proxy material | Jun 15, 2026 | — |
| DEF 14A | Proxy statement | Jun 15, 2026 | Jul 31, 2026 |
| DEFA14A | Additional proxy material | May 19, 2025 | — |
| DEF 14A | Proxy statement | May 19, 2025 | Jul 3, 2025 |
| DEFA14A | Additional proxy material | May 3, 2024 | — |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 6, 2024 |
| DEF 14A | Proxy statement | Nov 20, 2023 | Dec 15, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 9, 2023 | Nov 9, 2023 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | Jun 7, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2023 | Apr 10, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 23, 2022 |
| DEF 14A | Proxy statement | Dec 4, 2020 | Dec 22, 2020 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- JSPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1788028
- Former names
- Amplitude Healthcare Acquisition Corp (until Sep 29, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.